tetano
Editor, Senior Moderator
Virol J
. 2024 Nov 26;21(1):304.
doi: 10.1186/s12985-024-02555-z. Genomic surveillance and evolutionary dynamics of influenza a virus in Sri Lanka
Tibutius Thanesh Pramanayagam Jayadas[SUP] 1 [/SUP], Chandima Jeewandara[SUP] 1 [/SUP], Bhagya Senadheera[SUP] 1 [/SUP], Heshan Kuruppu[SUP] 1 [/SUP], Rivindu Wickramanayake[SUP] 1 [/SUP], Padukkage Harshani Chathurangika[SUP] 1 [/SUP], Nushara Senatilleke[SUP] 1 [/SUP], Navanjana Warnakulasuriya[SUP] 1 [/SUP], Farha Bary[SUP] 1 [/SUP], Ananda Wijewickrama[SUP] 2 [/SUP], Suranga Manilgama[SUP] 2 [/SUP], Manouri Gamage[SUP] 3 [/SUP], Nilanka Perera[SUP] 4 [/SUP], Graham S Ogg[SUP] 5 [/SUP], Gathsaurie Neelika Malavige[SUP] 6 7 [/SUP]
Affiliations
Background: Influenza A has been named as a priority pathogen by the WHO due to the potential to cause pandemics. Genomic sequencing of influenza strains is important to understand the evolution of the influenza strains and also to select the appropriate influenza vaccines to be used in the different influenza seasons in Sri Lanka. Therefore, we sought to understand the molecular epidemiology of the influenza viruses in the Western Province of Sri Lanka, including mutational analysis to investigate the evolutionary dynamics.
Methodology: A total of 349 individuals presenting with fever and respiratory symptoms were enrolled in this study from November 2022 to May 2024. Nasopharyngeal and oropharyngeal specimens were collected and screened using quantitative PCR to detect Influenza A, Influenza B, and SARS-CoV-2. Subtyping and genomic sequencing was carried out on influenza A strains using Oxford Nanopore Technology.
Results: Influenza A was detected in 49 (14%) patients, influenza B in 20 (5.7%) and SARS-CoV-2 in 41 (11.7%). Co-infections were observed in five participants. The phylogenetic analysis assigned the H1N1 HA gene sequences within the 6B.1 A.5a.2a clade. The HA gene of the H1N1 sequences in 2023 were assigned as belonging to the subclades C.1, C.1.2, and C.1.8, while the 2024 sequences were assigned to subclades C.1.8 and C.1.9. The H3N2 sequences from 2023 were assigned to the 3 C.2a1b.2a.2a.1b clade and subclade G.1.1.2, while the 2024 sequences were assigned to the 3 C.2a1b.2a.2a.3a.1 clade and subclade J.2. The K54Q, A186T, Q189E, E224A, R259K, K308R, I418V, and X215A amino acid substitutions were seen in the H1N1 in the 2023 and 2024 sequences. The 2024 H1N1 sequences additionally exhibited further substitutions, such as V47I, I96T, T120A, A139D, G339X, K156X, and T278S.
Conclusion: In this first study using genomic sequencing to characterize the influenza A strains in Sri Lanka, which showed different influenza A viruses circulating in an 18-month period. As the Sri Lankan strains also had certain mutations of unknown significance, it would be important to continue detailed surveillance of the influenza strains in Sri Lanka to choose the most suitable vaccines for the population and the timing of vaccine administration.
Keywords: Clades; Genomic sequencing; Influenza A; Molecular epidemiology; SARS-CoV-2; Severe disease; Subtypes; Vaccines.
. 2024 Nov 26;21(1):304.
doi: 10.1186/s12985-024-02555-z. Genomic surveillance and evolutionary dynamics of influenza a virus in Sri Lanka
Tibutius Thanesh Pramanayagam Jayadas[SUP] 1 [/SUP], Chandima Jeewandara[SUP] 1 [/SUP], Bhagya Senadheera[SUP] 1 [/SUP], Heshan Kuruppu[SUP] 1 [/SUP], Rivindu Wickramanayake[SUP] 1 [/SUP], Padukkage Harshani Chathurangika[SUP] 1 [/SUP], Nushara Senatilleke[SUP] 1 [/SUP], Navanjana Warnakulasuriya[SUP] 1 [/SUP], Farha Bary[SUP] 1 [/SUP], Ananda Wijewickrama[SUP] 2 [/SUP], Suranga Manilgama[SUP] 2 [/SUP], Manouri Gamage[SUP] 3 [/SUP], Nilanka Perera[SUP] 4 [/SUP], Graham S Ogg[SUP] 5 [/SUP], Gathsaurie Neelika Malavige[SUP] 6 7 [/SUP]
Affiliations
- PMID: 39593174
- PMCID: PMC11590484
- DOI: 10.1186/s12985-024-02555-z
Background: Influenza A has been named as a priority pathogen by the WHO due to the potential to cause pandemics. Genomic sequencing of influenza strains is important to understand the evolution of the influenza strains and also to select the appropriate influenza vaccines to be used in the different influenza seasons in Sri Lanka. Therefore, we sought to understand the molecular epidemiology of the influenza viruses in the Western Province of Sri Lanka, including mutational analysis to investigate the evolutionary dynamics.
Methodology: A total of 349 individuals presenting with fever and respiratory symptoms were enrolled in this study from November 2022 to May 2024. Nasopharyngeal and oropharyngeal specimens were collected and screened using quantitative PCR to detect Influenza A, Influenza B, and SARS-CoV-2. Subtyping and genomic sequencing was carried out on influenza A strains using Oxford Nanopore Technology.
Results: Influenza A was detected in 49 (14%) patients, influenza B in 20 (5.7%) and SARS-CoV-2 in 41 (11.7%). Co-infections were observed in five participants. The phylogenetic analysis assigned the H1N1 HA gene sequences within the 6B.1 A.5a.2a clade. The HA gene of the H1N1 sequences in 2023 were assigned as belonging to the subclades C.1, C.1.2, and C.1.8, while the 2024 sequences were assigned to subclades C.1.8 and C.1.9. The H3N2 sequences from 2023 were assigned to the 3 C.2a1b.2a.2a.1b clade and subclade G.1.1.2, while the 2024 sequences were assigned to the 3 C.2a1b.2a.2a.3a.1 clade and subclade J.2. The K54Q, A186T, Q189E, E224A, R259K, K308R, I418V, and X215A amino acid substitutions were seen in the H1N1 in the 2023 and 2024 sequences. The 2024 H1N1 sequences additionally exhibited further substitutions, such as V47I, I96T, T120A, A139D, G339X, K156X, and T278S.
Conclusion: In this first study using genomic sequencing to characterize the influenza A strains in Sri Lanka, which showed different influenza A viruses circulating in an 18-month period. As the Sri Lankan strains also had certain mutations of unknown significance, it would be important to continue detailed surveillance of the influenza strains in Sri Lanka to choose the most suitable vaccines for the population and the timing of vaccine administration.
Keywords: Clades; Genomic sequencing; Influenza A; Molecular epidemiology; SARS-CoV-2; Severe disease; Subtypes; Vaccines.